IndraLab
Statements
Lithium(1+) inhibits TBK1. 4 / 4
|
4
reach
"Lithium has been shown to inhibit TBK1 kinase activity in a GSK3β-independent manner, attenuating TLR3/4 and RIG-I immune pathways that mediate IFNβ production and antiviral responses.39 Thus, lithium was assumed to have therapeutic potential to intervene in autoimmune diseases caused by uncontrolled IFN-β production."